Literature DB >> 19853380

The case for publishing 'negative' clinical trials.

Michael C Rowbotham1.   

Abstract

Mesh：

Year:  2009        PMID： 19853380     DOI： 10.1016/j.pain.2009.09.026

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  6 in total

1.  Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis.

Authors:  Robert H Dworkin; Dennis C Turk; Sarah Peirce-Sandner; Hua He; Michael P McDermott; John T Farrar; Nathaniel P Katz; Allison H Lin; Bob A Rappaport; Michael C Rowbotham
Journal:  Neurology       Date:  2013-05-22       Impact factor: 9.910

2.  A pain research agenda for the 21st century.

Authors:  Robert W Gereau; Kathleen A Sluka; William Maixner; Seddon R Savage; Theodore J Price; Beth B Murinson; Mark D Sullivan; Roger B Fillingim
Journal:  J Pain       Date:  2014-10-29       Impact factor: 5.820

Review 3.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

4.  Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases.

Authors:  Faustine L Dufka; Troels Munch; Robert H Dworkin; Michael C Rowbotham
Journal:  Pain       Date:  2015-01       Impact factor: 7.926

5.  How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).

Authors:  Faustine L Dufka; Robert H Dworkin; Michael C Rowbotham
Journal:  Neurology       Date:  2014-09-05       Impact factor: 9.910

6.  Ethical considerations in the design, execution, and analysis of clinical trials of chronic pain treatments.

Authors:  Michael C Rowbotham; Michael P McDermott
Journal:  Pain Rep       Date:  2018-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.